T Kufa1, V Chihota1, S Charalambous2, S Verver3, G Churchyard2. 1. The Aurum Institute, Johannesburg, South Africa. 2. The Aurum Institute, Johannesburg, South Africa ; School of Public Health, University of Witwatersrand, Johannesburg, South Africa. 3. Amsterdam Institute of Global Health and Development, University of Amsterdam, Amsterdam, The Netherlands ; The KNCV Tuberculosis Foundation, The Hague, The Netherlands.
Abstract
BACKGROUND: New tuberculosis (TB) vaccines are required to meet global targets for TB control. OBJECTIVES: To determine willingness to participate (WTP) in new TB vaccine trials, willingness to be vaccinated with a newly licensed TB vaccine and associated factors among human immunodeficiency virus (HIV) infected persons. SETTING: Two primary care clinics in South Africa. DESIGN: Cross-sectional study design. Participants were asked about WTP and willingness to be vaccinated. Demographic, clinical, knowledge of TB and perception of risk information were collected. Log binomial regression was used to determine associated factors. RESULTS: A total of 827 participants were included in the analysis: 80.4% female, 72.2% on antiretroviral therapy, median age 35 years (interquartile range [IQR] 29-42 years), CD4 count 523 cells/µl (IQR 427-659 cells/µl). WTP and willingness to be vaccinated were high, at 84.5% and 92.6%, respectively. WTP was associated with knowledge about TB (prevalence ratio [PR] 1.10, 95% confidence interval [CI] 1.03-1.17) and perception of risk (PR 1.07, 95%CI 1.01-1.13). Willingness to be vaccinated was associated with employment (PR 1.04, 95%CI 1.01-1.08) and perception of risk (PR 1.05, 95%CI 1.01-1.09). CONCLUSIONS: There was high WTP in TB vaccine trials and willingness to be vaccinated among HIV-infected patients with good TB knowledge and high perceived risk of contracting TB.
BACKGROUND: New tuberculosis (TB) vaccines are required to meet global targets for TB control. OBJECTIVES: To determine willingness to participate (WTP) in new TB vaccine trials, willingness to be vaccinated with a newly licensed TB vaccine and associated factors among human immunodeficiency virus (HIV) infectedpersons. SETTING: Two primary care clinics in South Africa. DESIGN: Cross-sectional study design. Participants were asked about WTP and willingness to be vaccinated. Demographic, clinical, knowledge of TB and perception of risk information were collected. Log binomial regression was used to determine associated factors. RESULTS: A total of 827 participants were included in the analysis: 80.4% female, 72.2% on antiretroviral therapy, median age 35 years (interquartile range [IQR] 29-42 years), CD4 count 523 cells/µl (IQR 427-659 cells/µl). WTP and willingness to be vaccinated were high, at 84.5% and 92.6%, respectively. WTP was associated with knowledge about TB (prevalence ratio [PR] 1.10, 95% confidence interval [CI] 1.03-1.17) and perception of risk (PR 1.07, 95%CI 1.01-1.13). Willingness to be vaccinated was associated with employment (PR 1.04, 95%CI 1.01-1.08) and perception of risk (PR 1.05, 95%CI 1.01-1.09). CONCLUSIONS: There was high WTP in TB vaccine trials and willingness to be vaccinated among HIV-infectedpatients with good TB knowledge and high perceived risk of contracting TB.
Authors: Carey Farquhar; Grace C John-Stewart; Francis N John; Marjory N Kabura; James N Kiarie Journal: AIDS Res Hum Retroviruses Date: 2006-06 Impact factor: 2.205
Authors: Linda M Kaljee; Van Pham; Nguyen Dinh Son; Nguyen Thai Hoa; Vu Dinh Thiem; Do Gia Canh; Le Thi Kim Thoa; Mohammad Ali; Rion Leon Ochiai; M Carolina Danovaro-Holliday; Camilo J Acosta; Bonita Stanton; John Clemens Journal: Trop Med Int Health Date: 2007-01 Impact factor: 2.622
Authors: Eugene Ruzagira; Symon Wandiembe; Leonard Bufumbo; Jonathan Levin; Matthew A Price; Heiner Grosskurth; Anatoli Kamali Journal: Trop Med Int Health Date: 2009-01-15 Impact factor: 2.622
Authors: J W McGrath; K George; G Svilar; E Ihler; D Mafigiri; M Kabugo; E Mugisha Journal: J Acquir Immune Defic Syndr Date: 2001-08-01 Impact factor: 3.731
Authors: Gambo Aliyu; Mukhtar Mohammad; Ahmed Saidu; Prosanta Mondal; Man Charurat; Alash'le Abimiku; Abdulsalami Nasidi; William Blattner Journal: AIDS Care Date: 2010-10
Authors: Susan P Buchbinder; Barbara Metch; Sarah E Holte; Susan Scheer; Anne Coletti; Eric Vittinghoff Journal: J Acquir Immune Defic Syndr Date: 2004-05-01 Impact factor: 3.731
Authors: Joyce L Browne; Connie O Rees; Johannes J M van Delden; Irene Agyepong; Diederick E Grobbee; Ama Edwin; Kerstin Klipstein-Grobusch; Rieke van der Graaf Journal: Trop Med Int Health Date: 2019-01-08 Impact factor: 2.622